Mineralys Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Mineralys Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MLYS
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.
CEOJon Congleton
CEOJon Congleton
Employees51
Employees51
HeadquartersRadnor, Pennsylvania
HeadquartersRadnor, Pennsylvania
Founded2019
Founded2019
Employees51
Employees51
MLYS Key Statistics
Market cap2.61B
Market cap2.61B
Price-Earnings ratio-11.28
Price-Earnings ratio-11.28
Dividend yield—
Dividend yield—
Average volume1.20M
Average volume1.20M
High today$33.63
High today$33.63
Low today$31.83
Low today$31.83
Open price$32.96
Open price$32.96
Volume1.59M
Volume1.59M
52 Week high$47.65
52 Week high$47.65
52 Week low$8.24
52 Week low$8.24
Stock Snapshot
Mineralys Therapeutics(MLYS) stock is priced at $33.63, giving the company a market capitalization of 2.61B. It carries a P/E multiple of -11.28.
As of 2026-01-12, Mineralys Therapeutics(MLYS) stock has fluctuated between $31.83 and $33.63. The current price stands at $33.63, placing the stock +5.7% above today's low and 0.0% off the high.
The Mineralys Therapeutics(MLYS)'s current trading volume is 1.59M, compared to an average daily volume of 1.2M.
During the past year, Mineralys Therapeutics(MLYS) stock moved between $8.24 at its lowest and $47.65 at its peak.
During the past year, Mineralys Therapeutics(MLYS) stock moved between $8.24 at its lowest and $47.65 at its peak.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own MLYS. This list is generated using Robinhood data, and it’s not a recommendation.